Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,539 JPY | +1.38% | -3.93% | -11.50% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
ETFs positioned on Fuji Pharma Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 19 M€ | +11.99% | ||
0.00% | 17 M€ | +15.35% | - | |
0.00% | 140,441 M€ | +17.26% | ||
0.00% | 63,295 M€ | +17.38% | - | |
0.00% | 20,360 M€ | +16.28% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.50% | 240M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 4554 Stock
- Funds and ETFs Fuji Pharma Co., Ltd.